Epilepsy and gamma-aminobutyric acid-mediated inhibition.
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology; D001640:Bicuculline; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D004827:Epilepsy / Q000201:enzymology / Q000378:metabolism*; D005968:Glutamate Decarboxylase / Q000037:antagonists & inhibitors / Q000378:metabolism; D006801:Humans; D007223:Infant; D051379:Mice; D009433:Neural Inhibition; D011955:Receptors, Drug; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism; D013329:Structure-Activity Relationship; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000378:metabolism*
D000613:Aminobutyrates; D000927:Anticonvulsants; D011955:Receptors, Drug; D005680:gamma-Aminobutyric Acid; D000612:4-Aminobutyrate Transaminase; D005968:Glutamate Decarboxylase; D001640:Bicuculline